Related Experiment Videos

Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease

Hiromi Muta1, Masahiro Ishii, Jun Furui

  • 1Department of Paediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan. qze05346@nifty.com

Acta Paediatrica (Oslo, Norway : 1992)
|February 2, 2006
PubMed

Insights

Male sex, disease recurrence, and initial intravenous gamma-globulin (IVGG) treatment within 4 days at a dose of 1,000 mg/day or less are key factors predicting the need for IVGG re-treatment in Kawasaki disease patients.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Immunology

Background:

  • Kawasaki disease (KD) is a critical pediatric illness.
  • Intravenous gamma-globulin (IVGG) is the primary treatment for KD.
  • Understanding factors necessitating IVGG re-treatment is crucial for optimizing patient management.

Purpose of the Study:

  • To identify independent risk factors associated with the need for IVGG re-treatment in patients with Kawasaki disease.
  • To analyze characteristics of KD patients requiring repeat IVGG therapy.

Main Methods:

  • Analysis of data from the 17th nationwide survey in Japan.
  • Inclusion of 11,366 KD patients: 1,855 requiring re-treatment and 9,511 responders.
  • Multivariate logistic regression analysis to identify independent risk factors.

Main Results:

  • Male sex, complete KD cases, disease recurrence, and IVGG treatment within 4 days of illness onset were significant risk factors for re-treatment.
  • Specific clinical features like exanthema, oral lesions, peripheral extremity changes, and cervical lymphadenopathy were also associated with re-treatment.
  • Lower initial IVGG daily dose (<1,000 mg/Kg) was linked to a higher likelihood of needing re-treatment.

Conclusions:

  • Male sex, disease recurrence, and early IVGG treatment (within 4 days) at a lower dose (≤1,000 mg/day) are independent predictors for IVGG re-treatment in Kawasaki disease.
  • These findings aid in identifying high-risk patients who may benefit from closer monitoring or alternative therapeutic strategies.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...